Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Pedersen

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Circulation|October 1, 1984
Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter TrialP A Sirnes, K Overskeid, T R Pedersen, et al.
Journal of Internal Medicine|February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trialI Holme, R Fayyad, O Faergeman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases StudyS Rollefstad, E Ikdahl, J Hisdal, et al.
Diabetes Research and Clinical Practice|July 6, 2013
Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia StudyP T Skretteberg, A N Grytten, K Gjertsen, et al.
Circulation|May 15, 1996
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival StudyT R Pedersen, J Kjekshus, K Berg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension studyH Holdaas, B Fellström, E Cole, et al.
Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
Journal of Cardiovascular Risk|April 28, 2001
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline dataH Holdaas, B Fellström, I Holme, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Circulation|October 1, 1984
Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter TrialP A Sirnes, K Overskeid, T R Pedersen, et al.
Journal of Internal Medicine|February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trialI Holme, R Fayyad, O Faergeman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases StudyS Rollefstad, E Ikdahl, J Hisdal, et al.
Diabetes Research and Clinical Practice|July 6, 2013
Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia StudyP T Skretteberg, A N Grytten, K Gjertsen, et al.
Circulation|May 15, 1996
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival StudyT R Pedersen, J Kjekshus, K Berg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension studyH Holdaas, B Fellström, E Cole, et al.
Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
Journal of Cardiovascular Risk|April 28, 2001
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline dataH Holdaas, B Fellström, I Holme, et al.
Pageof 5